<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1635">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02095600</url>
  </required_header>
  <id_info>
    <org_study_id>DB-SRS</org_study_id>
    <nct_id>NCT02095600</nct_id>
  </id_info>
  <brief_title>Radiosurgery for Drug Resistant Invalidating Tremor</brief_title>
  <acronym>DB-SRS</acronym>
  <official_title>Deep Brain Stimulation and Frameless Stereotactic Radiosurgery in the Treatment of Drug Resistant Invalidating Tremor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta</source>
  <oversight_info>
    <authority>Italy: The Italian Medicines Agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stereotactic lesioning of thalamus and basal ganglia for treatment of tremor is a well-known
      procedure which, prior to the introduction of deep brain stimulation, or DBS, was usually
      achieved using stereotactic surgical procedures.

      Radiosurgery of invisible targets to treat movement disorders and intractable pain are still
      the domain of frame-based procedures, due to the need of a solid reference system registered
      to the anterior commissure-posterior commissure (AC-PC) line, which allows the use of
      stereotactic atlases.

      In this study we want to utilize a mathematical method that uses atlas-derived stereotactic
      coordinates to perform frameless images-guided radiosurgery of such functional targets
      Particularly the aim of the present study is to investigate both the efficacy and the safety
      of the methodology to treat upper limb and hand tremor in elderly or in patients which are
      not ot susceptible of surgical procedures. For these reasons a dose escalation prospective
      trial have been designed.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Tremor control (improvement in FTMTRS and/or UPDRS motor)</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Tremor control (improvement in Fahn Tolosa Marin Tremor Rating Scale, FTMTRS, and/or Unified Parkinson's Disease Rating Scale, UPDRS, motor)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Targeting methodology validation (the lesions position, if present, will be compared to the treatment plan target position, deviations will be registered).</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The treatment safety will be evaluated. Toxicity will be registered according to NCI-CTCAE v3.</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The treatment safety will be evaluated. Toxicity will be registered according to National Cancer Institute-Common Terminology Criteria for Adverse Events Version 3,NCI-CTCAE v3.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">6</enrollment>
  <condition>Severe Upper Limb Tremor Refractory to Medical Therapy</condition>
  <arm_group>
    <arm_group_label>Radiosurgical thalamotomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiosurgical thalamotomy</intervention_name>
    <arm_group_label>Radiosurgical thalamotomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients affected by severe upper limb tremor refractory to medical therapy and who
             are candidate for a deep brain stimulation (DBS) procedure.

          -  Age: â‰¥ 18 years old

          -  Refusal of DBS procedure

          -  Written consent

        Exclusion Criteria:

          -  Pregnancy

          -  Allergy to contrast medium

          -  DBS procedure susceptibility, if not refused
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fondazione IRCCS Istituto Neurologico C. Besta, Unit of Radiotherapy</name>
      <address>
        <city>Milan</city>
        <zip>20133</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Fariselli, MD</last_name>
      <phone>+39022394</phone>
      <phone_ext>2157</phone_ext>
      <email>laura.fariselli@istituto-besta.it</email>
    </contact>
    <contact_backup>
      <last_name>Marcello Marchetti, MD</last_name>
      <phone>+39022394</phone>
      <phone_ext>2157</phone_ext>
      <email>marchetti.m@istituto-besta.it</email>
    </contact_backup>
    <investigator>
      <last_name>Laura Fariselli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 21, 2014</lastchanged_date>
  <firstreceived_date>March 21, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tremor</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
